Kanghong Pharmaceutical's Perampanel Tablets Proposed for Selection in the 12th National Drug Procurement

CLS··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Kanghong Pharmaceutical announced that its product Perampanel Tablets has been proposed for selection in the 12th round of national centralized drug procurement. The drug is indicated for the treatment of partial-onset seizures in adults and children aged 4 years and older.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews